Compare UL & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UL | MDT |
|---|---|---|
| Founded | 1930 | 1949 |
| Country | United Kingdom | Ireland |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.0B | 125.3B |
| IPO Year | N/A | N/A |
| Metric | UL | MDT |
|---|---|---|
| Price | $71.71 | $103.50 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 19 |
| Target Price | N/A | ★ $109.63 |
| AVG Volume (30 Days) | 3.4M | ★ 8.3M |
| Earning Date | 03-12-2026 | 02-17-2026 |
| Dividend Yield | ★ 3.20% | 2.79% |
| EPS Growth | N/A | ★ 12.98 |
| EPS | 3.32 | ★ 3.69 |
| Revenue | ★ $70,194,950,090.00 | $34,758,000,000.00 |
| Revenue This Year | N/A | $8.63 |
| Revenue Next Year | N/A | $5.84 |
| P/E Ratio | ★ $21.31 | $27.60 |
| Revenue Growth | N/A | ★ 5.34 |
| 52 Week Low | $61.11 | $79.55 |
| 52 Week High | $73.87 | $106.33 |
| Indicator | UL | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 76.01 | 63.75 |
| Support Level | $67.70 | $101.19 |
| Resistance Level | $67.82 | $105.50 |
| Average True Range (ATR) | 0.86 | 2.13 |
| MACD | 0.49 | 0.33 |
| Stochastic Oscillator | 98.74 | 79.01 |
Unilever is a diversified beauty, wellbeing, and personal care (44% of 2024 sales by value), homecare (20%), and packaged food (36%) company. Its brands include Dove personal-care products, Knorr soups and sauces, Hellmann's mayonnaise, Axe and Rexona deodorants, and TRESemmé haircare. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, and Wild deodorants. The company derives 58% of its sales from emerging markets and 42% from developed markets. The US is its largest market, accounting for around 20% of sales, followed by India, which accounts for 11% of sales.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.